SPECT imaging of serotonin2 receptors in depression

Psychiatry Res. 1992 Dec;45(4):227-37. doi: 10.1016/0925-4927(92)90018-y.

Abstract

Changes of serotonin2 (5HT2) receptors have been described in depression, and long-term antidepressant treatment has been shown to decrease the number of 5HT2 receptors. In this study, single photon emission computed tomography (SPECT), with 2-123I-ketanserin as a ligand, was used to investigate 5HT2 receptors in vivo in the brain of depressed patients and normal volunteers. A higher uptake of the tracer was observed in the parietal cortex of the patients, and there was a right greater than left asymmetry in the infero-frontal region of the depressed subjects and not in that of the control subjects. These findings could indicate changes in 5HT2 receptors in major depression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Brain / diagnostic imaging*
  • Brain / physiopathology
  • Brain Mapping
  • Cerebral Cortex / diagnostic imaging
  • Cerebral Cortex / physiopathology
  • Depressive Disorder / diagnostic imaging*
  • Depressive Disorder / physiopathology
  • Dominance, Cerebral / physiology
  • Female
  • Humans
  • Ketanserin / pharmacokinetics
  • Male
  • Middle Aged
  • Parietal Lobe / diagnostic imaging
  • Parietal Lobe / physiopathology
  • Receptors, Serotonin / physiology*
  • Tomography, Emission-Computed, Single-Photon*

Substances

  • Receptors, Serotonin
  • Ketanserin